Interleukin-33: A Double-Edged Sword in Sepsis

Area of Science:

• Immunology
• Sepsis Pathogenesis
• Cytokine Biology

Background:

• Sepsis remains a leading cause of mortality despite clinical advances.
• The precise mechanisms of systemic inflammation and organ damage in sepsis are not fully elucidated.
• Interleukin-33 (IL-33), a member of the IL-1 superfamily, exhibits dual cytokine and nuclear factor functions.

Purpose of the Study:

• To review the current understanding of IL-33's multifaceted role in the host immune response to sepsis.
• To highlight the "double-edged sword" nature of IL-33 in sepsis pathogenesis.
• To synthesize updated information on IL-33's impact on inflammation, immunosuppression, and organ damage.

Main Methods:

• Literature review of studies investigating IL-33 in sepsis models and patients.
• Analysis of IL-33's functions as both a pro-inflammatory cytokine and a regulator of gene transcription.
• Examination of IL-33's effects on immune cell modulation and organ injury in sepsis.

Main Results:

• IL-33 demonstrates a dichotomous effect in sepsis, contributing to bacterial clearance and improved survival.
• Conversely, IL-33 can exacerbate inflammation, induce immunosuppression, and promote organ damage.
• The net effect of IL-33 in sepsis is dependent on the timing, context, and specific immune pathways involved.

Conclusions:

• IL-33's dual role presents a complex therapeutic challenge in managing sepsis.
• Further research is needed to precisely define IL-33's contribution to sepsis outcomes.
• Targeting IL-33 pathways may offer novel strategies for sepsis treatment, but requires careful consideration of its opposing functions.